HCA Healthcare, Inc. (NYSE:HCA), a leading healthcare provider in the nation, presented its annual HCA Healthcare Awards of Distinction during a ceremony in Nashville, Tennessee. These awards, including the Frist…
Naveris, Inc., a leader in precision oncology diagnostics for viral-induced cancers, announced new data presentation at the 2024 Annual Meeting of the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS),…
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company focused on enhancing women’s health, has received U.S. FDA approval for the use of Motiva® SmoothSilk® Ergonomix® and Motiva®…
Phare Bio, in collaboration with the Collins Lab at MIT and Harvard’s Wyss Institute, announced they have secured up to $27 million in funding from the Advanced Research Projects Agency…
CleanNA, a leading Dutch manufacturer of magnetic bead-based nucleic acid extraction kits, has unveiled a CE-IVD compliant version of its flagship product, CleanNGS. The new CleanNGS Dx reagent is designed…
A study published in Nature Communications showcases how Depixus’ scalable single molecule technology offers detailed insights into RNA-ligand interactions, aiding the development of new therapeutics. Using magnetic force spectroscopy (MFS),…
GE Appliances, a leading home appliance manufacturer, has announced a significant partnership with Mothers’ Milk Bank Northeast, a nonprofit dedicated to supplying lifesaving pasteurized donor human milk to premature and…
ImageBloom, Inc., a leader in clinical trial support solutions, is thrilled to announce the launch of the Patient Recruitment Marketplace. This groundbreaking platform is set to transform patient recruitment for…
Aditxt, Inc. (NASDAQ: ADTX), an innovation platform aimed at accelerating health advancements, has announced that its majority-owned subsidiary, Pearsanta, Inc., has entered into a Market Development Collaboration Agreement with Evofem…
Genentech, part of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced positive topline results from the Phase III CENTERSTONE study of Xofluza® (baloxavir marboxil). The study showed that a…
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company specializing in cancer and autoimmune disease treatments, has received approval to conduct a clinical trial for its BCL2 inhibitor, ICP-248,…
Novostia, a leading medical technology company advancing a groundbreaking heart valve replacement, has announced a leadership change and secured CHF 5.6 million in funding. Soad El Ghazouani has been appointed…